Table 3.
Changes in caregiver distress scores between baseline and 6-month rivastigmine treatment
Caregiver distress score | Baseline | 6 months | p value |
---|---|---|---|
Total score | 8.1 ± 6.4 | 5.4 ± 7.4 | 0.020* |
Delusions | 0.5 ± 0.9 | 0.3 ± 0.8 | 0.194 |
Hallucinations | 0.6 ± 0.9 | 0.1 ± 0.3 | 0.026* |
Agitation and aggression | 0.5 ± 0.9 | 0.6 ± 1.2 | 0.809 |
Depression and dysphoria | 1.3 ± 0.9 | 0.6 ± 1.0 | 0.003† |
Anxiety | 1.4 ± 1.3 | 1.3 ± 1.6 | 0.512 |
Euphoria | - | - | 1.000 |
Apathy | 1.0 ± 1.3 | 0.3 ± 0.5 | 0.009† |
Disinhibition | 0.3 ± 0.8 | 0.4 ± 1.2 | 0.854 |
Irritability and lability | 0.6 ± 1.2 | 0.9 ± 1.3 | 0.286 |
Aberrant motor behavior | 0.5 ± 0.9 | 0.5 ± 1.0 | 1.000 |
Sleep disturbance | 0.8 ± 1.0 | 0.5 ± 1.2 | 0.367 |
Appetite changes | 0.7 ± 1.0 | 0.1 ± 0.3 | 0.023* |
Data represent mean ± standard deviation. Analyses were performed by Wilcoxon signed ranks test.
p < 0.05,
p < 0.001.